🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Chosa Oncology AB (FRA:W5L)
Germany flag Germany · Delayed Price · Currency is EUR
0.0392
+0.0062 (18.79%)
At close: Nov 18, 2026

Chosa Oncology AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
2.561.796.448.770.97
Cash & Short-Term Investments
2.561.796.448.770.97
Cash Growth
36.31%-72.18%-26.61%808.08%-
Other Receivables
1.361.691.230.750.23
Receivables
1.361.691.230.750.23
Prepaid Expenses
0.120.160.07--
Other Current Assets
--0---
Total Current Assets
4.043.637.749.531.2
Other Intangible Assets
8.398.189.569.910.7
Long-Term Deferred Charges
8.648.434.11--
Total Assets
21.0720.2521.419.4311.9

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
0.592.711.670.83-
Other Current Liabilities
1.370.991.11.180.28
Total Current Liabilities
1.963.712.772.020.28
Other Long-Term Liabilities
-0---
Total Liabilities
1.963.712.772.020.28

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
15.8214.212.7711.6812.68
Additional Paid-In Capital
15.96--6.09-
Comprehensive Income & Other
-12.672.345.86-0.35-1.07
Shareholders' Equity
19.1116.5418.6317.4111.61
Total Liabilities & Equity
21.0720.2521.419.4311.9

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash (Debt)
2.561.796.448.770.97
Net Cash Growth
36.31%-72.18%-26.61%808.08%-
Net Cash Per Share
0.030.020.090.140.05
Filing Date Shares Outstanding
87.8678.976.9464.8719.05
Total Common Shares Outstanding
87.8678.976.9464.8719.05
Working Capital
2.08-0.074.977.510.91
Book Value Per Share
0.220.210.240.270.61
Tangible Book Value
10.728.369.077.510.91
Tangible Book Value Per Share
0.120.110.120.120.05